Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)

China flag China · Delayed Price · Currency is CNY
78.71
-0.71 (-0.89%)
Jan 23, 2026, 3:00 PM CST
84.20%
Market Cap6.66B
Revenue (ttm)339.03M
Net Income (ttm)-25.96M
Shares Out83.87M
EPS (ttm)-0.28
PE Ration/a
Forward PEn/a
Dividend6.80 (8.02%)
Ex-Dividend DateSep 11, 2025
Volume2,576,744
Average Volume3,056,108
Open79.00
Previous Close79.42
Day's Range77.40 - 79.76
52-Week Range38.73 - 86.00
Beta0.73
RSI58.75
Earnings DateApr 23, 2026

About SHA:688399

Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. Jiangsu Bioperfectus Technologies Co., Ltd. was founde... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 592
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688399
Full Company Profile

Financial Performance

In 2024, SHA:688399's revenue was 349.61 million, a decrease of -13.29% compared to the previous year's 403.18 million. Losses were -2.00 million, -99.46% less than in 2023.

Financial Statements